Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: A randomized placebo-controlled double-blind prospective clinical study

European Urology

Volumn 48, Issue 4, 2005, Pages 656-661

  Riedl, Claus R ^a   Sternig, Peter ^b   Gallé, Günter ^c   Langmann, Florian ^d   Vcelar, Brigitta ^e   Vorauer, Karola ^f   Wagner, Andreas ^e   Katinger, Hermann ^e,f   Pflüger, Heinz ^d  

^a Thermenklinikum Baden Austria ^*  (Austria)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d Municipal Hospital Lainz   (Austria)

^e POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH   (Austria)

^f UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Controlled clinical trial; Local therapy; Medical therapy; Peyronie's disease; Superoxide dismutase

Indexed keywords

LIPOSOMAL RECOMBINANT SUPEROXIDE DISMUTASE; LIPOXYSAN; OXYGEN RADICAL; PLACEBO; RECOMBINANT ENZYME; SCAVENGER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANALGESIA; ARTICLE; BLISTER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFLAMMATION; MALE; PATIENT SATISFACTION; PEYRONIE DISEASE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CROSS-OVER STUDIES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DUPUYTREN'S CONTRACTURE; FREE RADICAL SCAVENGERS; HUMANS; LIPOSOMES; MALE; PAIN MEASUREMENT; PATIENT SATISFACTION; PENILE ERECTION; PENILE INDURATION; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 24644520785     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.04.011     Document Type: Article

References (29)

1. R.W. Lewis, and G.H. Jordan Peyronie's Disease P.C. Walsh A.B. Retik E.D. Vaughan Wein Campell's Urology 8th ed. 2002 Saunders Philadelphia (PA) 1696 1705
2. C.J. Devine Jr., K.D. Somers, G.H. Jordan, and S.M. Schlossberg Proposal: trauma as the cause of the Peyronie's lesion J Urol 157 1997 285
3. M.K. Gelbard, F. Dorey, and K. James The natural history of Peyronie's disease J Urol 144 1990 1376
4. P. Gontero, and B. Frea Are the current conservative treatments for Peyronie's Disease evidence-Based? Br J Urol Int 94 2004 3 4
5. LA. Levine, K.E. Goldman, and J.M. Greenfield Experience with intraplaque injection of verapamil for Peyronie's disease J Urol 168 2002 625 626 621-625; discussion
6. M.K. Gelbard, K. James, P. Riach, and F. Dorey Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study J Urol 149 1993 56 58
7. C.R. Riedl, E. Plas, P. Engelhardt, K. Daha, and H. Pflüger Iontophoresis for the treatment of Peyronie's disease J Urol 163 2000 95 99
8. F. Montorsi, A. Salonia, G. Guazzoni, L. Barbieri, R. Colombo, and M. Brausi Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results J Androl 21 2000 85 90
9. S.M. Di Stasi, A. Giannantoni, R.L. Stephen, G. Capelli, A. Giurioli, and E.A. Jannini A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease J Urol 171 2004 1605 1608
10. J.D.M. DeVries, J.A.F. Leenarts, E.J.H. Nieuleman, and F.M.J. Debruyne Die Behandlung der Peyronie's Disease mit SOD-Injektion. Attraktive Alternative zu den bisherigen Therapieverfahren? Akt Urol 6 1988 321
11. G. Bartsch, K.B. Menander-Huber, W. Huber, and H. Marberger Orgotein, a new drug for the treatment of Peyronie's disease Eur J Rheumatol Inflamm 4 1981 250
12. H. Gustafson, B. Johansson, and F. Edsmyr Peyronie's disease: experience of local treatment with orgotein Eur J Urol 7 1981 346
13. G. Primus Orgotein in the treatment of plastic induration of the penis (Peyronie's disease) Int Urol Nephr 25 1993 169
14. T. Berlin Orgotein versus hydrocortisone in the treatment of Peyronie's disease. A randomized study J Urol 135 1986 103A 392A
15. K. Bayer, A. Jungbauer, and K. Uhl Humane rekombinante Superoxiddismutase Bioengineering 6 1990 24 30
16. K. Vorauer, M. Skias, and A. Jungbauer Scale-up of recombinant protein purification by hydrophobic interaction chromatography J Chromatography 625 1992 217 226
17. K. Vorauer-Uhl, A. Wagner, and H. Katinger Long term stability of rh-Cu/Zn-superoxide dismutase (SOD)-liposomes prepared by the cross-flow injection technique following International Conference on Harmonisation (ICH)-guidelines Eur J Pharm Biopharm 54 2002 83 87
18. Schriebl K, Wagner A, Fürnschlief E, Katinger H, Vorauer-Uhl K. Aspects and limitations of in-vivo penetration studies of liposomal formulations - case study of liposomal human Cu/Zn-superoxide dismutase. Submitted to Int J Pharm, 2005.
19. A. Wagner, K. Vorauer-Uhl, and H. Katinger Liposomes produced in a pilot scale: production, purification and efficiency aspects Eur J Pharm Biopharm 54 2002 213 219
20. C.R. Riedl, E. Plas, K. Vorauer, B. Vcelar, A. Wagner, and H. Pfluger Pilot study on liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease Eur Urol 40 2001 343 348 [Discussion 348-9]
21. W. Weidner, and E.W. Hauck Schnitker K, and the Peyronie's Disease Study Group of the Andrological Group of the German Urologists. Potassium paraaminobenzoate (Potaba™) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study Eur Urol 47 2005 530 536
22. S.S. Gholami, N.F. Gonzalez-Cadavid, C.S. Lin, J. Rajfer, and T.F. Lue Peyronie's disease: a review J Urol 169 2003 1234 1241
23. A. Kadioglu, A. Tefekli, B. Erol, T. Oktar, M. Tunc, and S. Tellaloglu A retrospective review of 307 men with Peyronie's disease J Urol 168 2002 1075 1079
24. M.G. Ferrini, D. Vernet, T.R. Magee, A. Shahed, A. Qian, and J. Rajfer Antifibrotic role of inducible nitric oxide synthase Nitric Oxide 6 2002 283 294
25. D.J. Ralph, M.D. Brooks, G.F. Bottazzo, and J.P. Pryor The treatment of Peyronie's disease with tamoxifen Br J Urol 70 1992 648 651
26. Z.Q. Wang, F. Porreca, S. Cuzzocrea, K. Galen, R. Lightfoot, and E. Masini A newly identified role for superoxide in inflammatory pain J Pharmacol Exp Ther 309 2004 869 878
27. H. Lum, and K.A. Roebuck Oxidant stress and endothelial cell dysfunction Am J Physiol Cell Physiol 280 2001 719 741
28. E.W. Hauck, A. Hauptmann, S.M. Haag, and W. Weidner New insights into the etiological pathogenesis of Peyronie's disease Akt Urol 34 2003 387 391
29. W. Weidner, I. Schroeder-Printzen, J. Rudnick, W. Krause, W.H. Weiske, and B. Drawz Randomized prospective placebo-controlled therapy of Peyronie's disease (IPP) with Potaba (aminobenzoate potassium) J Urol 161 1999 4S